Certified by Founder Lodge
Secretome Therapeutics
United States - Baltimore, Maryland
START UP
1 Disclosed Funding Rounds $30,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Secretome Therapeutics is a clinical-stage cell therapy company focused on orphan and underserved cardiac diseases. STM-01, the lead drug, is a neonatal cardiac progenitor cell (nCPC) isolate
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 28 ,2026 | Series A | $30,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Itera | $12,000,000 | (May 28, 2026)
Protuoso Biosciences | $9,500,000 | (May 28, 2026)
ClearNote Health | $52,000,000 | (May 28, 2026)
Cypher AI | $2,000,000 | (May 28, 2026)
Fields Good | $1,800,000 | (May 28, 2026)
